Changes in metabolites, metabolic hormones, and luteinizing hormone before puberty in Angus, Braford, Charolais, and Simmental heifers

We determined changes in insulin, glucose, free fatty acids (FFA), growth hormone (GH), insulin-like growth factor I (IGF-I) and LH before puberty in Angus, Braford, Charolais, and Simmental heifers. Our primary objective was to identify metabolites and metabolic hormones that serve as metabolic cues for onset of puberty. Angus (n = 12). Braford (n = 7), Charolais (n = 9), and Simmental (n = 7) heifers were assigned at weaning (289 +/- 25 d of age; 264 +/- 23 kg) to open-sided pens with slotted floors, and they were fed a corn silage-concentrate diet formulated to provide gains of .91 kg/d. Puberty was defined as the 1st d (d 0) that serum progesterone (determined in blood samples collected at weekly intervals) exceeded 1 ng/ml. Blood samples were collected before and after feeding at 15-min intervals for 8 h at 21-d intervals before puberty in a subsample of heifers (at least five per breed). Angus and Simmental heifers weighed less and were younger (P less than .05) at puberty than Charolais and Braford heifers. Serum FFA before feeding and frequency of LH release increased (P less than .05) from d-40 +/- 3 to d-17 +/- 3 in all breeds. Conversely, concentrations of insulin were greater (P less than .05) at -40 than at -17 d from puberty in Angus, but not in Braford, Charolais, or Simmental heifers. Frequency of GH release was greater at d -40 than at d -17 in Angus heifers; however, in Braford and Charolais heifers frequency of GH release was greater at d -17 than at d -40. Concentrations of IGF-I (measured every 2 wk) increased linearly (P less than .07) from d -56 to 0 from puberty in Angus but not in other breeds. In conclusion, frequency of LH release and concentrations of FFA increased before puberty in all breeds; however, consistent changes in other metabolites and hormones were observed only in Angus heifers.     

Pruritus in rabbits, rodents, and ferrets

This article attempts to cover the more specific pruritic problems encountered in rabbits, rodents, and ferrets. There are certainly other causes of pruritus in these animals. Dermatophytes in guinea pigs are not reported to be pruritic, but because they are pruritic in other species, they should be considered in a differential diagnosis. A cryptococcal dermatitis in a guinea pig that was pruritic has been reported. Although mites were not seen on scraping, the animal was treated for sarcoptid mites and apparently the pruritus lessened. Because the cryptococcis was still present, it is questionable whether it was causing the pruritus. Pruritic ulcerative dermatitis over the back and shoulders has been seen in some lines of rats. Staphylococcus aureus was cultured from many of the lesions. Clipping the toenails on the feet helped lessen the severity of the lesions. Syphacia spp. have been reported in rats, gerbils, and hamsters and should be considered if there is perineal pruritus. MOBS, or "move over buddy syndrome," is seen especially in mice and may be seen in hamsters, gerbils, and rats that are overcrowded or stressed. The lesions are actually bite wounds that have been inflicted around the tail base and the perineum and on the tail, but these wounds can be mistaken for self-inflicted trauma from pruritus. All of the recommended treatments are extralabel, and clients should be informed of this. I have observed a guinea pig become lethargic and anorexic after only one application of a flea powder approved for use in cats. Brushing most of the powder off and offering dandelion greens to stimulate appetite helped. The second dusting was done with the same flea powder diluted with baby powder. Whenever these animals are dipped, it is important to let them dry in a warm, draft-free area. Again, it is important to be aware that the ratio of surface area to body weight is much higher in these small animals than in the species routinely seen in veterinary practice especially to prevent toxicoses from topically applied medications and iatrogenic hypothermia or hyperthermia.     

Serologic prevalence of toxoplasmosis in cattle, sheep, goats, pigs, bison, and elk in Montana

Serum samples from 2,539 cattle, 649 sheep, 123 goats, 413 pigs, 93 bison, and 56 elk from Montana were examined for antibody to Toxoplasma gondii in the Sabin-Feldman dye test or the modified agglutination test (MAT). Cattle, bison, and elk serum samples were treated with 0.2 M-mercaptoethanol before examination in MAT. In the dye test, 13.2% of sheep, 5.0% of pigs, and 22.7% of goats had antibody at a dilution of greater than or equal to 1:16. In the MAT, 3.2% of cattle, 3.1% of bison, and none of the elk were positive at a dilution of greater than or equal to 1:128.     

Occurrence, distribution, and role in abortion of Coxiella burnetii in sheep and goats in Sardinia, Italy

Between 1999 and 2002, 9349 sera and 517 aborted samples (422 foetuses and 95 placenta) were analysed from 675 sheep and 82 goat farms distributed all over the island of Sardinia. After abortion notification, sera collected at random from adult animals were examined to detect antibodies specific to Coxiella burnetii by ELISA, whereas foetuses and placenta were analysed by PCR assay. Specific IgG antibodies were detected in 255 (38%) sheep farms and in 39 (47%) goat herds whereas 40 ovine (10%) and 3 (6%) caprine foetuses were C. burnetii PCR-positive. Although C. burnetii DNA was amplified from different types of tissues, placenta was the tissue with the highest detection rate. Seroprevalence analysis indicates that C. burnetii distribution in sheep and goats is very high, but PCR results demonstrate that C. burnetii has a relatively low role in abortion, especially in goats.     

虚拟现实中的VR、AR、MR和CR

整个社会对虚拟现实的研究和开发源于上个世纪六十年代,计算机图形学、人机接口技术、图像处理与模式识别、多传感技术、语音处理与音响技术、高性能计算机系统、人工智能等领域在之后半个世纪取得了长足的发展为虚拟现实产业爆发打下的坚实的基础。那么问题来了,到底VR、AR、MR和CR说的是什么呢?     

Comparative cardiovascular, analgesic, and sedative effects of medetomidine, medetomidine-hydromorphone, and medetomidine-butorphanol in dogs

OBJECTIVE: To compare sedative, analgesic, and cardiopulmonary effects after IV administration of medetomidine (20 microg/kg), medetomidine-hydromorphone (20 microg of medetomidine/kg and 0.1 mg of hydromorphone/kg), and medetomidine-butorphanol (20 microg of medetomidine/kg and 0.2 mg of butorphanol tartrate/kg) in dogs. ANIMALS: 6 dogs healthy mixed-breed dogs. PROCEDURE: Instruments were surgically inserted, and heart rate (HR), respiratory rate (RR), systolic arterial pressure (SAP), mean arterial pressure (MAP), diastolic arterial pressure (DAP), mean pulmonary arterial pressure (MPAP), pulmonary capillary wedge pressure (PCWP), central venous pressure (CVP), core body temperature, and cardiac output (CO) were measured 0, 5, 10, 15, 30, 45, and 60 minutes after injection. Cardiac index (CI), stroke volume (SV), stroke index (SI), systemic vascular resistance (SVR), and pulmonary vascular resistance (PVR) were calculated. Arterial samples for blood gas analysis were collected 0, 15, and 45 minutes after injection. Intensity of analgesia, degree of sedation, and degree of muscle relaxation were evaluated at aforementioned time points and 75, 90, 120, 150, 180, and 210 minutes after injection. RESULTS: Administration of medetomidine, medetomidine-hydromorphone, and medetomidine-butorphanol was associated with increases in SAP, MAP, DAP, MPAP, PCWP, CVP, SVR, PVR, core body temperature, and PaCO2 and decreases in HR, CO, CI, SV, SI, RR, pH, and PaO2. Clinically important differences were not detected among treatments. Medetomidine-hydromorphone and medetomidine-butorphanol provided a longer duration of sedation and better quality of analgesia, compared with medetomidine alone. CONCLUSIONS AND CLINICAL RELEVANCE: Medetomidine-hydromorphone or medetomidine-butorphanol is associated with improved analgesia and sedation but has cardiopulmonary effects comparable to those for medetomidine alone.     

Changes in plasma melanocyte-stimulating hormone,ACTH, prolactin,GH, LH,FSH, and thyroid-stimulating hormone in response to injection of sulpiride,thyrotropin-releasing hormone,or vehicle in insulin-sensitive and -insensitive mares

Six insulin-sensitive and 6 insulin-insensitive mares were used in a replicated 3 by 3 Latin square design to determine the pituitary hormonal responses (compared with vehicle) to sulpiride and thyrotropin-releasing hormone (TRH), 2 compounds commonly used to diagnose pituitary pars intermedia dysfunction (PPID) in horses. Mares were classified as insulin sensitive or insensitive by their previous glucose responses to direct injection of human recombinant insulin. Treatment days were February 25, 2012, and March 10 and 24, 2012. Treatments were sulpiride (racemic mixture, 0.01 mg/kg BW), TRH (0.002 mg/kg BW), and vehicle (saline, 0.01 mL/kg BW) administered intravenously. Blood samples were collected via jugular catheters at −10, 0, 5, 10, 20, 30, 45, 60, 90, and 120 min relative to treatment injection. Plasma ACTH concentrations were variable and were not affected by treatment or insulin sensitivity category. Plasma melanocyte-stimulating hormone (MSH) concentrations responded (P < 0.01) to both sulpiride and TRH injection and were greater (P < 0.05) in insulin-insensitive mares than in sensitive mares. Plasma prolactin concentrations responded (P < 0.01) to both sulpiride and TRH injection, and the response was greater (P < 0.05) for sulpiride; no effect of insulin sensitivity was observed. Plasma thyroid-stimulating hormone (TSH) concentrations responded (P < 0.01) to TRH injection only and were higher (P < 0.05) in insulin-sensitive mares in almost all time periods. Plasma LH and FSH concentrations varied with time (P < 0.05), particularly in the first week of the experiment, but were not affected by treatment or insulin sensitivity category. Plasma GH concentrations were affected (P < 0.05) only by day of treatment. The greater MSH responses to sulpiride and TRH in insulin-insensitive mares were similar to, but not as exaggerated as, those observed by others for PPID horses. In addition, the reduced TSH concentrations in insulin-insensitive mares are consistent with our previous observation of elevated plasma triiodothyronine concentrations in hyperleptinemic horses (later shown to be insulin insensitive as well).     

Exercise-induced alterations in plasma concentrations of ghrelin, adiponectin, leptin, glucose, insulin, and cortisol in horses

Six Standardbred (STB) mares (11+/-2 years, 521+/-77 kg; means+/-SD) performed an exercise trial (EX) where they underwent an incremental exercise test (GXT) as well as a parallel control trial (CON) to test the hypothesis that short-term, high intensity exercise would alter plasma concentrations of glucose, leptin, adiponectin, ghrelin, insulin and cortisol. Plasma samples were taken before (0 min), during (last 10s at 6, 8m/s, and the velocity eliciting VO(2max)), and after exercise (2, 10, 30, 60 min; 12 and 24h post-GXT). A second set of blood samples was collected before and after an afternoon meal given at 1515 h (at 1500, 1514, 1530, and 1545 h). Data were analyzed using ANOVA for repeated measures and Tukey's test. During the GXT, there were no changes (P>0.05) in the plasma concentrations of glucose, leptin, adiponectin or ghrelin. However, there was a 29% increase (P<0.05) in mean plasma cortisol concentration and a 35% decrease (P<0.05) in mean plasma insulin concentration. Substantial increases (P<0.05) in the mean plasma concentrations of glucose and cortisol of 36% and 102%, respectively, were seen in the EX trial during the first 60 min post-GXT. Plasma leptin concentration, measured at the 24h post-GXT time point, was 20% lower (P<0.05) during the EX trial compared with the parallel time point in the standing control (CON) trial. Plasma ghrelin concentration was 37% lower (P<0.05) in the EX trial compared with CON before and after the afternoon meal, but was 43% higher (P<0.05) 12h post-GXT. There were no differences between EX and CON for plasma concentrations of insulin or adiponectin during recovery. It was concluded that short-term high intensity exercise alters plasma leptin and ghrelin concentrations in STB mares post-exercise, which may signal the exercised animals to alter energy intake.     

Effects of butorphanol, flunixin, levorphanol, morphine, and xylazine in ponies

The analgesic and behavioral effects of butorphanol (0.22 mg/kg), flunixin (2.2 mg/kg), levorphanol (0.033 mg/kg), morphine (0.66 mg/kg), and xylazine (2.2 mg/kg), given IM were observed in 8 ponies. These ponies were instrumented to measure response objectively to painful superficial and visceral stimuli. Effects on the cardiopulmonary system and rectal temperature also were evaluated in 6 of these ponies. Observations were conducted before drug injection (base-line values) and after injection at 30, 60, 120, 180, and 240 minutes. Xylazine provided the highest pain threshold for the first 60 minutes and a sedative effect for 105 minutes. The effects for superficial pain and visceral pain persisted 3 hours and 4 hours, respectively. Morphine produced good analgesia for superficial pain (30 minutes), whereas butorphanol provided good effect for visceral pain (4 hours). A slight degree of analgesia for visceral pain was obtained after morphine (1 hour) and levorphanol (4 hours); flunixin did not induce analgesia. Butorphanol, levorphanol, and morphine stimulated motor activity. Behavioral effects did not occur after flunixin was given. Xylazine decreased systolic, diastolic, and mean blood pressures. Marked increases in these pressures, heart rate, and respiratory rate were observed after morphine was given. Changes of central venous pressure, rectal temperature, and blood gas values remained within base-line limits after both drugs were given. Butorphanol increased heart rates for 1 hour; flunixin and levorphanol did not alter any of the above values.     

Cholangitis in cats: symptoms, cause, diagnosis, treatment, and prognosis

Inflammation of the bile ducts is common in cats. This review article reports on what is currently known about the various types of cholangitis (i.e., cholangitis caused by liver flukes, neutrophilic cholangitis, and lymphocytic cholangitis). Treatment is available for cholangitis caused by liver flukes and for neutrophilic cholangitis, and the prognosis is good. However, the cause of lymphocytic cholangitis is not known and there is currently no evidence-based therapy. Several causes are mentioned in the literature, but more research is needed in order to establish the cause of this disease and to develop an appropriate therapy.     

Observational study of temperature,moisture, pH and bacteria in straw bedding,and faecal consistency,cleanliness and mastitis in cows in four dairy herds

A study of four dairy farms showed that much of the straw stored for bedding was too wet (over 15 per cent moisture content). Most of the beds, including their top surfaces, were damp (above 75 per cent relative humidity). The temperature of the surface of most of the straw beds was related to the air temperature, many being below 15 degrees C, but below the surface the temperatures of most beds reached between 15 degrees C and 45 degrees C within about a week of their being renewed. Bacterial counts also reached a plateau within one to two weeks. The pH of the top layers of straw was usually between 8.5 and 9.5. Adding lime daily to the top layer of the straw failed to raise the pH to levels at which Escherichia coli and Streptococcus uberis do not survive. Most of the counts of E coli and faecal streptococci in the top layers of straw were above 10(6) colony-forming units/g. Counts of E coli and S uberis were much higher in the beds of early lactation cows than in those of dry cows. Many of the early lactation cows were heavily and persistently contaminated with faeces. Dry cows were much cleaner. Groups of cows with firmer faeces were also cleaner. The farm with the lowest incidence of mastitis had the cleanest cows and the most satisfactory beds.     

P-glycoprotein in intestines, liver, kidney and lymphocytes in horse

P-glycoprotein (P-gp) is an important drug transporter, which is expressed in a variety of cells, such as the intestinal enterocytes, the hepatocytes, the renal tubular cells and the intestinal and peripheral blood lymphocytes. We have studied the localization and the gene and protein expression of P-gp in these cells in horse. In addition we have compared the protein sequence of P-gp in horse with the protein sequences of P-gp in several other species. Real time RT-PCR and Western blot showed gene and protein expression of horse P-gp in all parts of the intestines, but there was no strict correlation between these parameters. Immunohistochemistry showed localization of P-gp in the apical cell membranes of the enterocytes and, in addition, staining was observed in the intestinal intraepithelial and lamina propria lymphocytes. Peripheral blood lymphocytes also stained for P-gp, and gene and protein expression of P-gp were observed in these cells. There was a high gene and protein expression of P-gp in the liver, with P-gp-immunoreactivity in the bile canalicular membranes of the hepatocytes. Gene and protein expression of P-gp were found in the kidney with localization of the protein in different parts of the nephrons. Protein sequence alignment showed that horse P-gp has two amino acid insertions at the N-terminal region of the protein, which are not present in several other species examined. One of these is a 99 amino acid long sequence inserted at amino acid positions 23–121 from the N-terminal. The other is a six amino acid long sequence present at the amino acid positions 140–145 from the N-terminal. The results of the present study indicate that P-gp has an important function for oral bioavailability, distribution and excretion of substrate compounds in horse.     

Weaning,yearling, and preharvest ultrasound measures of fat and muscle area in steers,bulls, and heifers

Longissimus muscle area and fat thickness were measured following weaning, at yearling, and prior to harvest using real-time ultrasound, and corresponding carcass measurements were recorded 3 to 7 d following the preharvest scan in composite steers (n = 116, 447 +/- 19 d), bulls (n = 224, 521 +/- 11 d), and heifers (n = 257,532 +/- 12 d). Although fat deposition was limited in bulls and heifers from weaning to yearling, coefficients of variation ranged from 8.46 to 13.46% for muscle area, and from 27.55 to 38.95% for fat thickness, indicating that significant phenotypic variance exists across genders. Residual correlations, adjusted for the effects of year of birth, gender, and age at measurement, were high and ranged from 0.79 to 0.87 among ultrasound and carcass measures of muscle area. Residual correlations among ultrasound and carcass measures of fat thickness were also high, ranging from 0.64 to 0.86. Weaning and/or yearling ultrasound muscle area yielded similarly accurate predictions of carcass muscle area. Yearling ultrasound fat thickness accounted for 13% more of the observed variance in carcass fat thickness than the weaning ultrasound measure in single-trait prediction models. When both weaning and yearling ultrasound measures were used to predict carcass fat thickness, partial R2 values were 0.15 and 0.61 for weaning and yearling ultrasound fat thickness, respectively. The difference between predicted and carcass measures with respect to muscle area (fat thickness) was less than 6.45 cm2 (2.5 mm) for 80.2 to 88.9% (90.3 to 95%) of animals. Preharvest ultrasound measures yielded standard errors of prediction of less than 4.95 cm2 for muscle area and 1.51 mm or less for fat thickness. These results indicate that ultrasound measures taken between weaning and yearling provide accurate predictors of corresponding carcass traits in steers, bulls, and heifers.